Myelofibrosis is a rare cancer that affects your bone marrow, the spongy tissue inside some of your bones. In a healthy person, stem cells in the bone marrow make the red blood cells, white blood ...
A phase 2 study evaluated the use of ruxolitinib plus standard GVHD prophylaxis in patients with myelofibrosis undergoing ...
GSK's cancer unit has been given a fillip by the FDA with a broader-than-expected approval for JAK inhibitor momelotinib for anaemia associated with myelofibrosis, acquired as part of its $1.9 ...
and X-linked protoporphyria (XLP), DISC-0974 for myelofibrosis (MF) anemia and chronic kidney disease (CKD) anemia, and DISC-3405, an anti-TMPRSS6 monoclonal antibody. Bitopertin, an oral GlyT1 ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback